Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;170(3):634-44.
doi: 10.1002/ajmg.a.37468. Epub 2015 Dec 8.

MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis

Debra S Regier  1 , Hyuk Joon Kwon  2 , Jean Johnston  1   2 , Gretchen Golas  1 , Sandra Yang  3 , Edythe Wiggs  1 , Yvonne Latour  2 , Sarah Thomas  2 , Cindy Portner  4 , David Adams  1   2 , Gilbert Vezina  5 , Eva H Baker  6 , Cynthia J Tifft  1   2
Affiliations

MRI/MRS as a surrogate marker for clinical progression in GM1 gangliosidosis

Debra S Regier et al. Am J Med Genet A. 2016 Mar.

Abstract

Background GM1 gangliosidosis is a lysosomal storage disorder caused by mutations in GLB1, encoding β-galactosidase. The range of severity is from type I infantile disease, lethal in early childhood, to type III adult onset, resulting in gradually progressive neurological symptoms in adulthood. The intermediate group of patients has been recently classified as having type II late infantile subtype with onset of symptoms at one to three years of age or type II juvenile subtype with symptom onset at 2-10 years. To characterize disease severity and progression, six Late infantile and nine juvenile patients were evaluated using magnetic resonance imaging (MRI), and MR spectroscopy (MRS). Since difficulties with ambulation (gross motor function) and speech (expressive language) are often the first reported symptoms in type II GM1, patients were also scored in these domains. Deterioration of expressive language and ambulation was more rapid in the late infantile patients. Fourteen MRI scans in six Late infantile patients identified progressive atrophy in the cerebrum and cerebellum. Twenty-six MRI scans in nine juvenile patients revealed greater variability in extent and progression of atrophy. Quantitative MRS demonstrated a deficit of N-acetylaspartate in both the late infantile and juvenile patients with greater in the late infantile patients. This correlates with clinical measures of ambulation and expressive language. The two subtypes of type II GM1 gangliosidosis have different clinical trajectories. MRI scoring, quantitative MRS and brain volume correlate with clinical disease progression and may serve as important minimally-invasive outcome measures for clinical trials.

Keywords: GM1 gangliosidosis; MRI; MRS; lysosomal storage disease; trial readiness.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources